HZNP News and Press, Horizon Therapeutics Public Limited Company From 05/17/23

2023-05-17 00:19:41 ET Summary Soros' 13F portfolio value decreased from $7.26B to $6.49B this quarter. The number of positions decreased from 208 to 185. Soros increased Horizon Therapeutics and Splunk while decreasing Rivian, Amazon, Alphabet, and First Horizon. Horizon Ther...

2023-05-16 14:30:14 ET Pfizer ( NYSE: PFE ) received more than $85B in orders on Tuesday as it kicked off an investment-grade jumbo bond sale, one of the biggest in history, to finance its proposed acquisition of Seagen ( NASDAQ: SGEN ), Bloomberg reported citing a perso...

2023-05-16 14:16:31 ET Summary Biotech giant Amgen Inc. is facing a lawsuit from the FTC attempting to block its acquisition of Horizon Therapeutics Public Limited Company, a deal worth around $25 billion. The FTC's opposition is centered on the potential for Amgen to exploit Hori...

2023-05-16 14:04:07 ET The Federal Trade Commission's lawsuit seeking to stop Amgen's ( NASDAQ: AMGN ) acquisition of Horizon Therapeutics ( HZNP ) could negatively impact current and future biotech deals, according to two Street firms. Wells Fargo noted that if the FTC'...

2023-05-16 12:56:20 ET Major market averages were lower during Tuesday's midday session as investors await the outcome of the debt ceiling negotiations between congressional leaders and President Joe Biden. Tracking individual stocks, Sea Limited ( NYSE: SE ) and iQIYI ( NASDA...

2023-05-16 12:36:00 ET The stock market was mixed at midday on Tuesday, as investors tried to reach a comfort level with the state of the global economy and the combination of near-term and longer-term factors affecting businesses and their strategic vision. Although the Nasdaq Composite ...

Horizon Therapeutics plc (Nasdaq: HZNP) today issued the following statement in response to the FTC’s complaint seeking to block Amgen’s proposed acquisition of the Company: “This acquisition has the potential to accelerate the availability of important rare disease medic...

2023-05-16 11:14:01 ET Shares of Horizon Therapeutics (NASDAQ: HZNP) , a rare disease specialist, were down by 17.4% on heavy volume as of 10:14 a.m. ET Tuesday morning. The drugmaker's shares are falling after news broke that the Federal Trade Commission (FTC) plans to seek an ...

2023-05-16 10:49:10 ET The Federal Trade Commission filed a lawsuit to block Amgen's ( NASDAQ: AMGN ) $27.8 planned acquisition of Horizon Therapeutics ( NASDAQ: HZNP ). Horizon fell 15%. The complaint was filed in Illinois federal court, according to a Bloomberg r...

2023-05-16 10:25:23 ET Amgen ( NASDAQ: AMGN ) is expected to mount a "very aggressive" defense if the Federal Trade Commission files a lawsuit to block the $28 billion acquisition of Horizon Therapeutics ( NASDAQ: HZNP ), according to CNBC. FTC commissioners have not y...